Anti-Tumor Innate Immunity Activated by Intermittent Metronomic Cyclophosphamide Treatment of 9L Brain Tumor Xenografts Is Preserved by Anti-Angiogenic Drugs That Spare VEGF Receptor 2

Molecular Cancer - United Kingdom
doi 10.1186/1476-4598-13-158
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Stimulation of Anti-Tumor Immunity by Photodynamic Therapy

Expert Review of Clinical Immunology
AllergyImmunology
2011English

Anti-Nkg2a mAb Is a Checkpoint Inhibitor That Promotes Anti-Tumor Immunity by Unleashing Both T and NK Cells

Cell
BiochemistryGeneticsMolecular Biology
2018English

Anterior Gradient�2 as a Supervisory Marker for Tumor Vessel Normalization Induced by Anti‑angiogenic Treatment

Oncology Letters
Cancer ResearchOncology
2018English

Suppression of Tumor Rejection by Autologous Anti-Idiotypic Immunity

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1980English

Postsurgical Adjuvant Tumor Therapy by Combining Anti-Angiopoietin-2 and Metronomic Chemotherapy Limits Metastatic Growth

Cancer Cell
Cancer ResearchOncologyCell Biology
2014English

Anti-Tumor Immunity Induced by Ectopic Expression of Viral Antigens Is Transient and Limited by Immune Escape

OncoImmunology
OncologyAllergyImmunology
2019English

Radiotherapy Effects on Anti-Tumor Immunity: Implications for Cancer Treatment

Frontiers Research Topics
2013English

Anti-Angiogenic Alternatives to VEGF Blockade

Clinical and Experimental Metastasis
MedicineCancer ResearchOncology
2015English

Anti-Angiogenic and Tumor-Suppressive Roles of Candidate Tumor-Suppressor Gene, Fibulin-2, in Nasopharyngeal Carcinoma

Oncogene
Cancer ResearchGeneticsMolecular Biology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy